The multifaceted aspects of refractory lupus nephritis
- PMID: 25487410
- DOI: 10.1586/1744666X.2015.990883
The multifaceted aspects of refractory lupus nephritis
Abstract
The term refractory lupus nephritis is generally used to indicate cases that do not respond to traditional treatment. However, the clinical presentation of lupus nephritis is variable and the time to response depends on the typology of the underlying renal syndrome. The criteria and the time for response are different in lupus patients with nephritic flares, in those with nephrotic syndrome, and in those with asymptomatic renal disease. In this paper, we will focus on the clinical characteristics, the consequences, and the possible therapeutic approaches for patients with different forms of refractory lupus nephritis, defined on the basis of renal syndrome at presentation.
Keywords: lupus nephritis; nephritic flares; nephrotic syndrome; refractory nephritis; systemic lupus erythematosus.
Similar articles
-
[The clinical importance of determining the von Willebrand factor in patients with lupus nephritis].Ter Arkh. 1995;67(5):14-6. Ter Arkh. 1995. PMID: 7638767 Russian.
-
Retrospective analysis of patients with lupus nephritis: data from a large clinical immunological center in Hungary.Scand J Immunol. 2006 Oct;64(4):433-7. doi: 10.1111/j.1365-3083.2006.01833.x. Scand J Immunol. 2006. PMID: 16970686
-
Predictive value of clinical, laboratory, pathologic, and treatment variables in steroid/immunosuppressive resistant lupus nephritis.J Clin Apher. 1988;4(1):30-4. doi: 10.1002/jca.2920040107. J Clin Apher. 1988. PMID: 3391988
-
Managing lupus nephritis: algorithms for conservative use of renal biopsy.Cleve Clin J Med. 1996 Mar-Apr;63(2):106-15. doi: 10.3949/ccjm.63.2.106. Cleve Clin J Med. 1996. PMID: 8819695 Review.
-
Mesangial lupus nephritis with associated nephrotic syndrome.J Am Soc Nephrol. 1997 Jul;8(7):1199-204. doi: 10.1681/ASN.V871199. J Am Soc Nephrol. 1997. PMID: 9219171 Review.
Cited by
-
Multifunctional Polydopamine-Based Nanoparticles for Dual-Mode Imaging Guided Targeted Therapy of Lupus Nephritis.Pharmaceutics. 2022 Sep 20;14(10):1988. doi: 10.3390/pharmaceutics14101988. Pharmaceutics. 2022. PMID: 36297424 Free PMC article.
-
Outcome of participants with nephrotic syndrome in combined clinical trials of lupus nephritis.Lupus Sci Med. 2019 Feb 4;6(1):e000308. doi: 10.1136/lupus-2018-000308. eCollection 2019. Lupus Sci Med. 2019. PMID: 31080631 Free PMC article.
-
Serum IFN-γ Predicts the Therapeutic Effect of Belimumab in Refractory Lupus Nephritis Patients.Pharmgenomics Pers Med. 2024 Sep 30;17:443-452. doi: 10.2147/PGPM.S476308. eCollection 2024. Pharmgenomics Pers Med. 2024. PMID: 39376665 Free PMC article.
-
Changing paradigms in the treatment of systemic lupus erythematosus.Lupus Sci Med. 2019 Feb 8;6(1):e000310. doi: 10.1136/lupus-2018-000310. eCollection 2019. Lupus Sci Med. 2019. PMID: 31168398 Free PMC article.
-
Immunosuppressive Treatment for Lupus Nephritis: Long-Term Results in 178 Patients.Biomed Res Int. 2016;2016:7407919. doi: 10.1155/2016/7407919. Epub 2016 Dec 5. Biomed Res Int. 2016. PMID: 28050564 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources